Harbour Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
AIM
FWIA
DLA
Harbour Investment Management's BMY Position: Q2 2026 in Review
Harbour Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 1.7% in Q2 2026, selling an estimated $23K and leaving 22,964 shares worth $1.32M. The position accounts for 0.68% of the portfolio, ranked #43.
Harbour Investment Management first reported a position in BMY in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.94M in Q1 2023. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Harbour Investment Management held 22,964 shares of Bristol-Myers Squibb worth $1.32M as of Q2 2026.
- Harbour Investment Management sold 400 Bristol-Myers Squibb shares in Q2 2026, an estimated $23K.
- Bristol-Myers Squibb made up 0.68% of Harbour Investment Management's portfolio in Q2 2026, its #43 holding.
- Harbour Investment Management first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 20 quarters since.
- Harbour Investment Management's Bristol-Myers Squibb position peaked at $1.94M in Q1 2023.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Harbour Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.